Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
64235,GNRL,"Stryker Corporation",MI,100000010503,104.83,08/31/2015,GNRL,324512422
64235,GNRL,"GENZYME CORPORATION",MA,100000000297,94.86,04/07/2014,GNRL,188522300
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,29.95,10/01/2013,GNRL,23818400
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,29.95,10/15/2015,GNRL,275719160
64235,GNRL,"Amgen Inc.",CA,100000000203,21.82,09/24/2015,GNRL,297819910
64235,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,21.18,10/08/2015,GNRL,290208932
64235,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,19.99,11/19/2015,GNRL,256054268
64235,GNRL,"SHIONOGI INC",NJ,100000005589,19.32,08/20/2013,GNRL,103380266
64235,GNRL,"Stryker Corporation",MI,100000010503,18.32,08/31/2015,GNRL,324512424
64235,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,18.08,08/13/2013,GNRL,24051759
64235,GNRL,"Meda Pharmaceuticals, Inc.",NJ,100000011184,17.52,02/18/2014,GNRL,221138654
64235,GNRL,"Novo Nordisk Inc",NJ,100000000144,17.21,07/09/2015,GNRL,266864736
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,16.98,07/08/2015,GNRL,275719156
64235,GNRL,"EISAI INC.",NJ,100000000136,16.62,04/22/2015,GNRL,337949384
64235,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.57,02/19/2015,GNRL,256317950
64235,GNRL,"Lilly USA, LLC",IN,100000000066,15.64,10/23/2015,GNRL,268119664
64235,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.64,06/16/2015,GNRL,266832760
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,15.07,08/12/2015,GNRL,275719158
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,14.13,04/14/2015,GNRL,275719154
64235,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,14.00,12/02/2014,GNRL,194684566
64235,GNRL,"Meda Pharmaceuticals, Inc.",NJ,100000011184,13.68,09/23/2014,GNRL,221169626
64235,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.60,11/12/2014,GNRL,162250394
64235,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.09,03/04/2014,GNRL,148967356
64235,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.86,07/15/2014,GNRL,148689008
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.82,02/11/2015,GNRL,275719162
64235,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,12.81,04/30/2014,GNRL,197551450
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.59,06/03/2014,GNRL,156769810
64235,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.43,01/20/2015,GNRL,256138548
64235,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.22,04/01/2014,GNRL,194684560
64235,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,12.21,01/27/2015,GNRL,290208934
64235,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,12.04,02/04/2014,GNRL,146998266
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.01,09/17/2013,GNRL,23818402
64235,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.97,02/11/2014,GNRL,194684558
64235,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,11.90,02/03/2015,GNRL,320788227
64235,GNRL,"Purdue Pharma L.P.",CT,100000005432,11.73,08/27/2013,GNRL,24362392
64235,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.62,04/22/2014,GNRL,148341880
64235,GNRL,"Lilly USA, LLC",IN,100000000066,11.58,04/07/2015,GNRL,268119666
64235,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,11.45,02/24/2015,GNRL,320788236
64235,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.33,10/21/2014,GNRL,194684564
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,10.93,06/03/2014,GNRL,156769808
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,10.79,01/13/2015,GNRL,275719166
64235,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.78,03/11/2014,GNRL,148213968
64235,GNRL,"Valeritas, Inc.",NJ,100000010873,10.73,03/24/2015,GNRL,324686180
64235,GNRL,"LILLY USA, LLC",IN,100000000066,10.55,11/04/2014,GNRL,137622318
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,10.43,10/01/2013,GNRL,23818404
64235,GNRL,"AbbVie, Inc.",IL,100000000204,10.43,09/19/2013,GNRL,31116548
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,10.37,09/30/2014,GNRL,156769816
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,8.67,10/08/2015,GNRL,275719176
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,8.44,05/19/2015,GNRL,275719168
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,8.23,11/18/2014,GNRL,156769820
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,7.91,07/23/2015,GNRL,275719170
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,7.08,07/07/2014,GNRL,156769812
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,5.94,12/10/2015,GNRL,275719152
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,5.07,08/28/2014,GNRL,156769814
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,4.82,09/23/2015,GNRL,275719174
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,4.75,11/10/2015,GNRL,275719150
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,3.38,03/13/2015,GNRL,275719180
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,2.94,01/12/2015,GNRL,275719164
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,2.04,07/23/2015,GNRL,275719172
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,1.23,11/18/2014,GNRL,156769818
64235,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,1.21,12/04/2014,GNRL,194684568
64235,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,1.01,02/11/2015,GNRL,275719178
64235,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,0.53,03/31/2014,GNRL,194684562
64235,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,0.30,02/10/2014,GNRL,194684556
